This cross-sectional study examines the prevalence and spending of patients with end-stage kidney disease in the individual market.
No takes yet. Share an insight, caveat, or question.
Trish et al. (2021) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: